Tyler W McCullock

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Molecular pharmacology

PloS one

eLife

bioRxiv : the preprint server for biology

University of Rochester (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Rochester

United States

PHD :: Pharmacology and Physiology

University of Rochester

United States

MSC :: Pharmacology and Physiology

Rensselaer Polytechnic Institute

United States

BSC :: Chemistry

Publications

Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling specificity and kinetics of the human metabotropic glutamate receptors. bioRxiv : the preprint server for biology (2023)
Tyler Couch, Kyle Berger, Dana L Kneisley, Tyler W McCullock, Paul Kammermeier, David M Maclean
Topography and motion of acid-sensing ion channel intracellular domains. eLife 10 (2021)
Tyler W McCullock, David M MacLean, Paul J Kammermeier
Comparing the performance of mScarlet-I, mRuby3, and mCherry as FRET acceptors for mNeonGreen. PloS one 15 (2) (2020)
Tyler W McCullock, Paul J Kammermeier
Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist. Pharmacology research & perspectives 7 (3) (2019)

Tyler W McCullock.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tyler W McCullock